UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fine-tuning alloreactivity against HLA-DP to control leukemia with tolerable graft- versus -host disease

Haematologica (Roma), 2023-02, Vol.108 (2), p.301-302

2023

Volltextzugriff (PDF)

Graft-vs-host disease following allogeneic hematopoietic cell transplantation

Cancer control, 2011-10, Vol.18 (4), p.268-276

Pidala, Joseph

2011

Volltextzugriff (PDF)

Clinical impact of clonal hematopoiesis in hematopoietic cell transplantation: a review, metaanalysis, and call to action

Haematologica (Roma), 2024-06

2024

Volltextzugriff (PDF)

Quality of life after allogeneic hematopoietic cell transplantation

Blood, 2009-07, Vol.114 (1), p.7-19

2009

Volltextzugriff (PDF)

Chronic graft-versus-host disease: unresolved complication or ancient history?

Blood, 2024-09, Vol.144 (13), p.1363-1373

2024

Volltextzugriff (PDF)

Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR

Blood, 2019-09, Vol.134 (12), p.924-934

2019

Volltextzugriff (PDF)

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation

Journal of clinical oncology, 2017-12, Vol.35 (36), p.4003-4011

2017

Volltextzugriff (PDF)

Evolving Therapeutic Options for Chronic Graft‐versus‐Host Disease

Pharmacotherapy, 2020-08, Vol.40 (8), p.756-772

2020

Volltextzugriff (PDF)

Progress in risk-adapted acute GVHD therapy

Blood, 2023-02, Vol.141 (5), p.443-444

Pidala, Joseph

2023

Volltextzugriff (PDF)

Health‐related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention

British journal of haematology, 2010-02, Vol.148 (3), p.373-385

2010

Volltextzugriff (PDF)

Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly

Blood, 2011-11, Vol.118 (20), p.5671-5680

2011

Volltextzugriff (PDF)

Biomarker Panel for Chronic Graft-Versus-Host Disease

Journal of clinical oncology, 2016-08, Vol.34 (22), p.2583-2590

2016

Volltextzugriff (PDF)

Sarcopenia and low muscle radiodensity associate with impaired FEV1 in allogeneic haematopoietic stem cell transplant recipients

Journal of cachexia, sarcopenia and muscle, 2020-12, Vol.11 (6), p.1570-1579

2020

Volltextzugriff (PDF)

Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in Mice

PloS one, 2015-09, Vol.10 (9), p.e0137641

2015

Volltextzugriff (PDF)

Associations of Germline Genetic Variants With Depression and Fatigue Among Hematologic Cancer Patients Treated With Allogeneic Hematopoietic Cell Transplantation

Psychosomatic medicine, 2023-11, Vol.85 (9), p.813-819

2023

Volltextzugriff (PDF)

Study protocol: Close Assessment and Testing for Chronic Graft-vs.-Host disease (CATCH)

PloS one, 2024-05, Vol.19 (5), p.e0298026

2024

Volltextzugriff (PDF)

Improved survival after acute graft- versus -host disease diagnosis in the modern era

Haematologica (Roma), 2017-05, Vol.102 (5), p.958-966

2017

Volltextzugriff (PDF)

Durable discontinuation of systemic therapy in patients affected by chronic graft- versus -host disease

Haematologica (Roma), 2023-02, Vol.108 (2), p.483-489

2023

Volltextzugriff (PDF)

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria

Blood, 2011-10, Vol.118 (15), p.4242-4249

2011

Volltextzugriff (PDF)

Mismatched donor allogeneic hematopoietic cell transplantation with post‐transplant cyclophosphamide achieves comparable outcomes between racially and ethnically diverse patient populations

American journal of hematology, 2024-06, Vol.99 (6), p.1196-1200

2024

Volltextzugriff (PDF)

Patient-reported treatment response in chronic graft- versus -host disease

Haematologica (Roma), 2024-01, Vol.109 (1), p.143

2024

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission

Cochrane database of systematic reviews, 2011-10 (10), p.CD008818

2011

Volltextzugriff (PDF)

1 – 25 von 475

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(326)
Mit Volltextzugriff
(438)

Publikationsform

Sprache

Englisch
(475)

Erscheinungsjahr

n.n

Thema

Science & Technology
(207)
Life Sciences & Biomedicine
(200)
Humans
(175)
Hematology
(160)
Transplantation
(129)
Male
(105)
Female
(104)
Adult
(101)
Immunology
(99)
Middle Aged
(97)
Aged
(72)
Hematology, Oncology And Palliative Medicine
(68)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(61)
Hematopoietic Stem Cell Transplantation
(54)
Transplantation, Homologous
(52)
Chronic Disease
(50)
Graft Vs Host Disease - Etiology
(49)
Graft Vs Host Disease - Prevention & Control
(49)
Adolescent
(41)
Graft Vs Host Disease - Mortality
(39)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Biology Of Blood And Marrow Transplantation
(141)
Blood
(103)
Transplantation And Cellular Therapy
(81)
Haematologica
(21)
Bone Marrow Transplantation
(18)
Blood Advances
(14)
Plos One
(9)
British Journal Of Haematology
(6)
Journal Of Clinical Oncology
(5)
Psycho-Oncology
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Fine-tuning alloreactivity against HLA-DP to control leukemia with tolerable graft- versus -host disease

Graft-vs-host disease following allogeneic hematopoietic cell transplantation

National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide

Clinical impact of clonal hematopoiesis in hematopoietic cell transplantation: a review, metaanalysis, and call to action

Quality of life after allogeneic hematopoietic cell transplantation

Chronic graft-versus-host disease: unresolved complication or ancient history?

Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation

Evolving Therapeutic Options for Chronic Graft‐versus‐Host Disease

Progress in risk-adapted acute GVHD therapy

Health‐related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention

Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation

Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial

Biomarker Panel for Chronic Graft-Versus-Host Disease

Sarcopenia and low muscle radiodensity associate with impaired FEV1 in allogeneic haematopoietic stem cell transplant recipients

Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in Mice

Associations of Germline Genetic Variants With Depression and Fatigue Among Hematologic Cancer Patients Treated With Allogeneic Hematopoietic Cell Transplantation

Study protocol: Close Assessment and Testing for Chronic Graft-vs.-Host disease (CATCH)

Improved survival after acute graft- versus -host disease diagnosis in the modern era

Durable discontinuation of systemic therapy in patients affected by chronic graft- versus -host disease

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria

Mismatched donor allogeneic hematopoietic cell transplantation with post‐transplant cyclophosphamide achieves comparable outcomes between racially and ethnically diverse patient populations

Patient-reported treatment response in chronic graft- versus -host disease

Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission

Suchergebnisse filtern